How have ELVN and IDYA total returns compared?

Over the past 5 years, ELVN delivered 24.57% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Enliven Therapeutics, Inc. (ELVN) vs IDEAYA Biosciences, Inc. (IDYA)

A side-by-side comparison of Enliven Therapeutics, Inc. and IDEAYA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ELVN

Enliven Therapeutics, Inc.

$3.06B

$42.80HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

IDYA

IDEAYA Biosciences, Inc.

$3.49B

$36.75HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

Total return — ELVN vs IDYA

growth of $100 · dividends reinvested · last 7y

ELVN -24.2% (-3.9%/yr)IDYA +826.0% (+37.4%/yr)IDYA compounded faster over this window

Log scale — wide-divergence pair

ELVN IDYA

ELVN vs IDYA: by the numbers

•IDYA is the larger company ($3.49B vs $3.06B market cap).
•Both run net losses; ELVN's is the smaller (0.00% vs -74.75% net margin).

Metrics side by side

Valuation

Metric	ELVN	IDYA
P/S ratio	N/A	14.93
P/B ratio	3.42	2.91

Profitability

Metric	ELVN	IDYA
Gross margin	0.00%	-43.89%
Operating margin	0.00%	-72.84%
Net margin	0.00%	-74.75%
ROE	-11.83%	-14.60%
ROIC	-13.88%	-17.68%

Growth (annualized)

Metric	ELVN	IDYA
Revenue CAGR (5Y)	N/A	45.80%
Total return CAGR (5Y)	24.57%	7.32%

Frequently asked

How have ELVN and IDYA total returns compared?: Over the past 5 years, ELVN delivered 24.57% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ELVN analysis Full IDYA analysis Interactive comparison tool

Dig into the metrics

Enliven Therapeutics ROE IDEAYA Biosciences ROE Enliven Therapeutics operating margin IDEAYA Biosciences operating margin Enliven Therapeutics revenue growth IDEAYA Biosciences revenue growth Enliven Therapeutics free cash flow IDEAYA Biosciences free cash flow

Enliven Therapeutics & IDEAYA Biosciences appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.